JP2023526332A5 - - Google Patents
Info
- Publication number
- JP2023526332A5 JP2023526332A5 JP2022569528A JP2022569528A JP2023526332A5 JP 2023526332 A5 JP2023526332 A5 JP 2023526332A5 JP 2022569528 A JP2022569528 A JP 2022569528A JP 2022569528 A JP2022569528 A JP 2022569528A JP 2023526332 A5 JP2023526332 A5 JP 2023526332A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- haloalkyl
- cycloalkyl
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063025474P | 2020-05-15 | 2020-05-15 | |
| US63/025,474 | 2020-05-15 | ||
| PCT/US2021/032495 WO2021231892A1 (en) | 2020-05-15 | 2021-05-14 | Certain chemical compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526332A JP2023526332A (ja) | 2023-06-21 |
| JP2023526332A5 true JP2023526332A5 (https=) | 2024-05-10 |
Family
ID=76270111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569528A Pending JP2023526332A (ja) | 2020-05-15 | 2021-05-14 | 特定の化学組成物およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11591322B2 (https=) |
| EP (1) | EP4149941B1 (https=) |
| JP (1) | JP2023526332A (https=) |
| KR (1) | KR20230051127A (https=) |
| CN (1) | CN116261561B (https=) |
| AU (1) | AU2021273072A1 (https=) |
| BR (1) | BR112022023199A2 (https=) |
| CA (1) | CA3178813A1 (https=) |
| ES (1) | ES3054109T3 (https=) |
| IL (1) | IL298219A (https=) |
| MX (1) | MX2022014356A (https=) |
| WO (1) | WO2021231892A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3054109T3 (en) | 2020-05-15 | 2026-01-29 | Algen Biotechnologies Inc | Certain chemical compositions and methods of use thereof |
| WO2023086417A1 (en) * | 2021-11-11 | 2023-05-19 | Algen Biotechnologies, Inc. | Compounds and methods of use thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4932412A (en) | 1986-12-18 | 1990-06-12 | Immunomedics, Inc. | Intraoperative and endoscopic tumor detection and therapy |
| EP1223952B1 (en) | 1999-10-07 | 2008-04-16 | Carlos Estuardo Aguilar-Cordova | Methods for treatment of solid tumors and metastasis by gene therapy |
| WO2004110350A2 (en) | 2003-05-14 | 2004-12-23 | Torreypines Therapeutics, Inc. | Compouds and uses thereof in modulating amyloid beta |
| WO2006071958A1 (en) | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| US8415381B2 (en) | 2009-07-30 | 2013-04-09 | Novartis Ag | Heteroaryl compounds and their uses |
| WO2012101065A2 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | Pyrimidine biaryl amine compounds and their uses |
| WO2012101063A1 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | N-acyl pyridine biaryl compounds and their uses |
| CN103339110A (zh) * | 2011-01-28 | 2013-10-02 | 诺瓦提斯公司 | 作为cdk9抑制剂的取代的杂-联芳基化合物及其用途 |
| WO2012101066A1 (en) | 2011-01-28 | 2012-08-02 | Novartis Ag | Pyridine biaryl amine compounds and their uses |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| EP3126525B1 (en) | 2014-04-04 | 2020-02-19 | Memorial Sloan-Kettering Cancer Center | Method and kits for identifying of cdk9 inhibitors for the treatment of cancer |
| NZ734082A (en) | 2015-01-20 | 2019-01-25 | Boehringer Ingelheim Animal Health Usa Inc | Anthelmintic compounds, compositions and method of using thereof |
| PL3429591T3 (pl) | 2016-03-16 | 2023-07-17 | Kura Oncology, Inc. | Podstawione pochodne tieno[2,3-d]pirymidyny jako inhibitory meniny-mll i metody ich zastosowania |
| EP3874045A4 (en) | 2018-10-31 | 2022-09-07 | The Regents of The University of California | Methods and kits for identifying cancer treatment targets |
| CN114025772A (zh) | 2019-04-24 | 2022-02-08 | 纪念斯隆凯特琳癌症中心 | 用于治疗ras突变体癌症的组合物和方法 |
| JP7677914B2 (ja) | 2019-06-21 | 2025-05-15 | アルゲン バイオテクノロジーズ，インク． | 標的遺伝子を特定するための方法およびシステム |
| EP4126918A4 (en) | 2020-03-31 | 2024-05-29 | The Regents of the University of California | COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR THE TREATMENT OF RNA VIRUS INFECTIONS |
| ES3054109T3 (en) | 2020-05-15 | 2026-01-29 | Algen Biotechnologies Inc | Certain chemical compositions and methods of use thereof |
| EP4185867A4 (en) | 2020-07-22 | 2024-08-07 | Algen Biotechnologies, Inc. | Methods and systems for determining drug effectiveness |
| WO2023086417A1 (en) | 2021-11-11 | 2023-05-19 | Algen Biotechnologies, Inc. | Compounds and methods of use thereof |
-
2021
- 2021-05-14 ES ES21730069T patent/ES3054109T3/es active Active
- 2021-05-14 KR KR1020227043684A patent/KR20230051127A/ko active Pending
- 2021-05-14 BR BR112022023199A patent/BR112022023199A2/pt unknown
- 2021-05-14 IL IL298219A patent/IL298219A/en unknown
- 2021-05-14 EP EP21730069.8A patent/EP4149941B1/en active Active
- 2021-05-14 AU AU2021273072A patent/AU2021273072A1/en active Pending
- 2021-05-14 CN CN202180059974.5A patent/CN116261561B/zh active Active
- 2021-05-14 JP JP2022569528A patent/JP2023526332A/ja active Pending
- 2021-05-14 CA CA3178813A patent/CA3178813A1/en active Pending
- 2021-05-14 WO PCT/US2021/032495 patent/WO2021231892A1/en not_active Ceased
- 2021-05-14 MX MX2022014356A patent/MX2022014356A/es unknown
-
2022
- 2022-04-28 US US17/731,943 patent/US11591322B2/en active Active
-
2023
- 2023-01-17 US US18/097,782 patent/US12264152B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534124A5 (https=) | ||
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP2019104748A5 (https=) | ||
| JP2023010738A (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| JP2007524696A5 (https=) | ||
| JP2015533782A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2020521740A5 (https=) | ||
| JP2021527638A5 (https=) | ||
| JP2020532547A5 (https=) | ||
| JP2010539110A5 (https=) | ||
| JP2019531279A5 (https=) | ||
| JP2018529739A5 (https=) | ||
| JP2019081762A5 (https=) | ||
| JP2016523973A5 (https=) | ||
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2008505171A5 (https=) | ||
| JP2010530403A5 (https=) | ||
| JP2013509431A5 (https=) | ||
| JP2006507355A5 (https=) | ||
| JP2014500322A5 (https=) | ||
| JP2023526332A5 (https=) | ||
| AR036366A1 (es) | Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit | |
| JP2021522262A5 (https=) | ||
| JP2022501334A5 (https=) | ||
| JP2019522628A5 (https=) |